The PRWIRE Press Releases https:// 2018-11-02T02:32:40Z G MEDICAL PURCHASES TELERHYTHMICS LLC, MEDICAL DIAGNOSTIC MONITORING SERVICE PROVIDER 2018-11-02T02:32:40Z g-medical-purchases-telerhythmics-llc-medical-diagnostic-monitoring-service-provider Expands infrastructure to increase nationwide footprint and services for remote vital signs monitoring healthcare services in the USA Provides additional capacity, access to technologies and payer network November 2, 2018 - Sydney, Australia – Mobile and e-Health company G Medical Innovations Holdings Ltd (G Medical or the Company) (ASX: GMV) is pleased to announce that its wholly owned Delaware incorporated subsidiary, G Medical Innovations USA Inc, has executed an agreement to acquire 100% of the outstanding membership interest of Telerhythmics LLC (Telerhythmics) (a Tennessee limited liability company), a US based cardiac diagnostic monitoring services provider. Telerhythmics, based outside Memphis, Tennessee, is a 24-hour cardiac diagnostic monitoring service used by hospitals and physician offices, and provides its monitoring services throughout the eastern region of the U.S. G Medical will acquire all the outstanding membership interests of Telerhythmics from NASDAQ listed imaging technologies company Digirad Corp (NASDAQ: DRAD) for a total up front consideration of US$1,950,000, subject to working capital adjustments. Completion of the agreement remains subject to the satisfaction of certain customary conditions precedent, including the receipt of any necessary consents from third parties including but not limited to government authorities. Telerhythmics, LLC., booked historical revenue from 1 January 2018 to 30 September 2018 of ~US$3.174M1 . The Telerhythmics acquisition, in addition to the Company’s acquisition of Cardiostaff Diagnostic Services Inc (as announced on 30 October 2017) will create a sizable player in the cardiac diagnostic US monitoring space, and in addition, provide G Medical with a solid base of business across the Southeast and Southwest territories. Telerhythmics is a Medicare and Medicaid designated IDTF (Independent Diagnostic Testing Facility) that provides physician practices and hospitals with arrhythmia monitoring services including mobile cardiac telemetry ("MCT"), cardiac event monitoring, Holter monitoring, and pacemaker analysis. The Telerhythmics acquisition will substantially increase insurance coverage and create a distinct competitive advantage, providing G Medical with ~100 commercial payor agreements across local, regional and national markets and an additional 30-35M covered lives (individuals insured); with the Company’s aggregated sum increasing to ~100M+ covered lives when considering existing G Medical Diagnostic Services payor agreements. Via the acquisition, G Medical will also gain access to several large health systems including Baptist, Ochsner, and HCA, and also to existing agreements in place with large insurance providers such as Blue Cross Blue Shield (BCBS), which has current reimbursement status for MCT (auto detect auto send) monitoring device. Further, Page 2 of 3 the Company’s regulatory approved medical devices will be translated to existing customers of both Telerhythmics and G Medical, providing for a superior technology offering and monitoring services when compared to traditional Holter monitoring. Telerhythmics, LLC., was established in 1996. It has long been recognized for superior clinical patient monitoring given its foundation of employing experienced critical care nurses. Telerhythmics’ business is synergistic and complementary to G Medical’s existing infrastructure and operations following the Company’s successful acquisition and integration of CardioStaff, and further increases the Company’s nationwide footprint and services for remote vital signs monitoring healthcare services across the US. Commenting on the latest acquisition, G Medical CEO Dr. Yacov Geva, said: “Acquiring Telerhythmics further strengthens our Company’s US footprint as we further focus our efforts to become a leader in complete (endto-end) and comprehensive vital signs medical monitoring and cardiac diagnostic services across the US. Telerhythmics brings additional payer contracts, clinical and commercial scalability, access to current monitoring technologies and an existing platform to launch our proprietary medical devices with the aim to further grow our market share in this important area of digital health delivery.” Cardiac diagnostic monitoring and remote vital signs monitoring healthcare services is a rapidly growing industry in the US and the Company is well positioned to become an emerging leader in the E-Health and Vital Signs Monitoring space. The Company continues its preparations towards the submission of its F-1 Registration Statement towards a Dual-Listing on the NASDAQ Stock Exchange, where a number of the Company’s peers are currently listed. About G Medical Products G Medical offers a suite of consumer and professional clinical-grade products (with regulatory approval) that are positioned to streamline healthcare services, improve remote access to medical data, reduce costs, improve quality of care, and make healthcare more personalized and precise. Currently the Company is focusing on two main verticals. The ‘Prizma’ Medical Smartphone Case is one of two key products developed by G Medical and is aimed at everyday consumers focused on their medical health and wellbeing. The ‘Prizma’ allows consumers to turn their smartphone into a mobile medical monitor to measure a wide range of vital signs, with the added advantage that users are able to store their medical data in the cloud and share it with third parties such as healthcare professionals and family members. G Medical also offers a professional real-time patient continuous monitoring solution, G Medical’s Vital Signs Monitoring System (VSMS) and G Medical Patch (GMP). This modular solution measures a wide range of vital signs that are automatically presented in a call centre (IDTF) or a hospital setting. The GMP assists in diagnosing patient complaints and conditions remotely, from pre-hospitalisation, hospitalisation and through to post discharge home-based settings. - Ends - Contact: Corporate Advisors Otsana Capital 108 Outram Street West Perth WA 6005 Telephone: +61 8 9486 7244 www.otsana.com Investor Relations Viriathus Australia Level 8/525 Flinders Street Melbourne VIC 3000 Telephone: +61 2 8667 5360 www.viriathus.com Media Enquiries Closer Communications David Wolf Tel: + 61 411 111 787 david@closer.com.au About G Medical Innovations G Medical (ASX: GMV) was founded in August 2014, aiming to be at the forefront of the digital health revolution, developing the next generation of mobile health (mHealth) technologies. The Company leverages the experience and expertise of its Board to deliver best-in-class solutions to address this global opportunity. The Company specialises in innovative next generation mobile and e-health solutions and services using its suite of devices and software solutions with a view to driving multiple and recurring revenue streams, across numerous verticals and territories. For more information on G Medical, please visit www.gmedinnovations.com CE, FDA & CFDA Approval Granted for Guangzhou China Production Facility 2018-10-30T05:04:29Z ce-fda-cfda-approval-granted-for-guangzhou-china-production-facility October 30, 2018 – Sydney, Australia – Mobile and e-Health company G Medical Innovations Holdings Ltd (“G Medical” or the “Company”) (ASX: GMV) is pleased to announce it has successfully completed the independent audit process to achieve CE, FDA and CFDA regulatory approval for the Company’s Production Facility in Guangzhou China. The Company is proud to inform its shareholders that it achieved excellent results during the multistage independent audit process conducted during September and October for all three regulatory bodies (CE, FDA and CFDA). The full audit has now been completed, and the results of the audit are expected to be published and searchable to the public later this week via the following directory; https://www.sgsgroup.com.cn/en/certified-clients-and-products/certified-client-directory The Company expects to receive its final certification documentation from the Regulatory bodies within 3 weeks. This is a significant milestone for the Company which intends to utilise the full production capacity of its Guangzhou facility. As previously announced to the market, the Company has numerous agreements in place globally and the approvals granted for the Guangzhou Facility enables the Company to commence production and distribution to those territories which recognise CE, FDA and CFDA certification and have already granted regulatory approval for the Company’s medical devices. G Medical CEO Dr. Yacov Geva said, “We are very pleased to have achieved CE, FDA and CFDA approval, which exemplifies the high-quality of our Production Facility and our strong in-Country relationships. The Company has been committed to achieving this major milestone in record timeframes and we now look forward to being able to meet the demand from our global partnerships and rapidly execute our commercial plans.” G Medical has a strong pipeline of customer demand and the increased production capacity positions the Company to fulfil its expansion into the rapidly growing E-Health market. As the Company continues its preparations for the listing of its Chinese subsidiary, Guangzhou Yimei Innovative Medical Science and Technology Co. Ltd, on the main board of The Hong Kong Stock Exchange (HKSE), the granting of CE, FDA and CFDA approval was an important achievement in this process. The Company requests that its securities stay in trading halt, pending an announcement in respect of a convertible note capital raising and a material acquisition. The Company requests the trading halt until the market opens on 31 October 2018 or until the announcement is made, whichever is the earlier. Corporate Advisors Otsana Capital 108 Outram Street West Perth WA 6005 Telephone: +61 8 9486 7244 www.otsana.com Investor Relations Viriathus Australia Level 8/525 Flinders Street Melbourne VIC 3000 Telephone: +61 2 8667 5360 www.viriathus.com Media Enquiries Closer Communications David Wolf Tel: + 61 411 111 787 david@closer.com.au About G Medical Innovations G Medical (ASX: GMV) was founded in August 2014, aiming to be at the forefront of the digital health revolution, developing the next generation of mobile health (mHealth) technologies. The Company leverages the experience and expertise of its Board to deliver best-in-class solutions to address this global opportunity. The Company specialises in innovative next generation mobile and e-health solutions and services using its suite of devices and software solutions with a view to driving multiple and recurring revenue streams, across numerous verticals and territories. For more information on G Medical, please visit www.gmedinnovations.com Natural medicine industry welcomes Wentworth victory for Dr Kerryn Phelps 2018-10-25T01:05:32Z natural-medicine-industry-welcomes-wentworth-victory-for-dr-kerryn-phelps-1 Media Announcement: 25 October 2018 Natural medicine industry welcomes Wentworth victory for Dr Kerryn Phelps The largest Australian body representing 10,000 natural medicine practitioners, The Australian Traditional-Medicine Society (ATMS), today welcomed the historic victory for Dr Kerryn Phelps on securing her seat in Wentworth following the by-election. Dr Phelps recently spoke at a Candidates Forum in Wentworth hosted by ATMS with Angela Vithoulkhas, Licia Heath and Shayne Higson. The candidates presented their positions on natural medicine, healthcare and small business with strong support from all candidates for complementary medicine, recognising its current role as a viable option for the health and wellbeing of Australians. ATMS are thrilled that Dr Phelps has gained the seat and support her principles of continued coverage of natural therapies within health funds, despite changes being implemented by the current Government. Charles Wurf, CEO, ATMS stated, “The election of a candidate who is supportive of complementary medicine is critical in this current environment seeking to remove subsidies for private health insurance. Further changes forecast by the recently announced Labor policy would seek to remove the GST exemption for naturopathy and herbal medicine treatments.” “ATMS maintains that restricting the choice of natural medicine treatments available within health insurance will prove a false economy. Policies targeted at limiting effective, proven natural medicine treatments will lead to greater pressure on public health and public hospitals,” finished Mr Wurf. ATMS looks forward to working with Dr Phelps and like-minded, committed Parliamentarians to ensure natural medicine treatments are available as effective, viable choices within the Australian healthcare and wellness system. To see how ATMS are representing natural medicine professionals in Australia, visit: www.atms.com.au -Ends- NOTES TO EDITORS: Interviews with: Charles Wurf, CEO, ATMS, are available on request through the below contacts For media enquiries please contact: Debbie Bradley, Group Account Director, Zadro P: 02 9212 7867 | debbie@zadroagency.com.au Sinead Andrews, Account Coordinator, Zadro P: 02 9212 7867 | sinead@zadroagency.com.au Image: Charles Wurf, CEO, ATMS About the Australian Traditional-Medicine Society: The Australian Traditional-Medicine Society (ATMS) is the leader of the natural medicine industry, promoting and representing professional practitioners of natural medicine, who are encouraged to pursue the highest ideals of professionalism in their natural medicine practice and education. As Australia’s largest national professional association for natural medicine practitioners, ATMS is a multi-disciplinary association representing over 10,000 accredited practitioners throughout Australia. ATMS was founded in 1984 and is an incorporated not-for-profit company. In 2014 ATMS celebrated their 30th anniversary representing natural medicine practitioners in Australia. ATMS is governed by a Board of Directors, with specialised departments for Massage Therapy, Chinese Medicine, Homeopathy, Nutrition, Naturopathy and Western Herbal Medicine. www.atms.com.au G MEDICAL ENGAGES US UNDERWRITER TO MANAGE DUAL-LISTING ON NASDAQ 2018-10-01T23:22:12Z g-medical-engages-us-underwriter-to-manage-dual-listing-on-nasdaq October 2, 2018 – Sydney, AUSTRALIA - Mobile and e-Health company G Medical Innovations (ASX: GMV) (“G Medical” or the “Company”) has today engaged a New York based Underwriter, to assist in the processes towards a US Public Offering via the NASDAQ Stock Exchange. The Company will remain listed on the Australian Stock Exchange, and the management of G Medical have engaged an Underwriter who will now proceed with submission of the F-1 Registration Statement with all parties working towards a US listing within the next 4 to 5 months. G Medical cautions investors that there can be no certainty that the proposed US listing will proceed. Investors should note that the listing is subject to satisfaction of all legal and regulatory requirements with NASDAQ, SEC and ASX, as well as any shareholder approvals that may be required under the ASX Listing Rules. Shareholders will be updated throughout the process as appropriate, and the amount of capital to be raised will be determined closer to the proposed offering. -ENDS- Corporate Advisors Otsana Capital 108 Outram Street West Perth WA 6005 Telephone: +61 8 9486 7244 www.otsana.com Investor Relations Viriathus Australia Level 8/525 Flinders Street Melbourne VIC 3000 Telephone: +61 2 8667 5360 www.viriathus.com Media Enquiries Closer Communications David Wolf Telephone: + 61 411 111 787 david@closer.com.au About G Medical Innovations G Medical (ASX: GMV) was founded in August 2014, aiming to be at the forefront of the digital health revolution, developing the next generation of mobile health (mHealth) technologies. The Company leverages the experience and expertise of its Board to deliver best-in-class solutions to address this global opportunity. The Company specialises in innovative next generation mobile and e-health solutions and services using its suite of devices and software solutions with a view to driving multiple and recurring revenue streams, across numerous verticals and territories. For more information on G Medical, please visit www.gmedinnovations.com IMC19 brings the future of science into focus 2018-09-25T22:43:44Z imc19-brings-the-future-of-science-into-focus-1 Critical discoveries and research that will help to transform health, science and industry are set to be the lasting legacy of the 19th International Microscopy Congress (IMC19), according to leaders of the scientific world. Held every four years, IMC19 saw more than 2,100 of the world’s top scientists and researchers from 48 countries come together at ICC Sydney to network, collaborate and discover the latest high-tech instrumentation and systems in microscopy and microanalysis. IMC19 also inspired the next generation of young scientists with its Schools Outreach Program, which welcomed 570 students from 19 schools. The program also featured a “Young Scientists Assembly” where 50 young scientists from around the world enjoyed the opportunity to discuss career planning with some of the most senior figures in the field. Professor Simon Ringer, Congress Chair, said the impact of IMC19 would be revealed over time from the global scientific community. “Innovations in microscopy enable us to extend our understanding of ourselves and the world around us. IMC19 brought together leaders in both the development and the application of microscopy in a huge range of disciplines,” he said. “These connections will ultimately lead to breakthroughs, as researchers take the insights from advanced microscopy to develop a treatment for cancer, a vaccine for a virus, or a new 3D printed metallurgical alloy that improves our atmosphere by being strong and light and thereby fuel and greenhouse gas efficient.” The week-long scientific program included presentations by four expert plenary speakers, two Nobel Laureates, 150 invited presenters as well as 26 pre-congress workshops and 463 oral talks, bridging the primary streams of Frontier Issues; Instrumentation and Techniques; Physical and Life Sciences. The pioneering IMC19 Outreach Learning Program welcomed high school students to experience the very latest light and electron microscope equipment and a chance to meet with researchers and specialists in microscopy. Mrs Diane Fairweather, Head of Science, Riverstone High School, said the program allowed students to access cutting-edge technology. “This was a great STEM initiative by IMC19 and an amazing experience for the students who came. We don’t have these microscopes at our school and without the IMC19 Outreach Program, most of our students wouldn’t be able to use this equipment,” said Fairweather. “Our students are engaged; they are learning directly from experts on things like using the lens to focus – it’s a real hands-on experience.” The Outreach Program offered students access to the latest equipment including, VR, four scanning electron microscopes, 20 life microscopes and 3D printing. Equipment and demonstrations were supported by Zeiss, Leica, AXT, Keepad Interactive, NewSpec, ATA, Coherent, UNSW Art and Design and Me3D. Citing recent examples of some of the life-changing advancements that have developed as a direct result of microscopy, Dr Alan Finkel, Australia’s Chief Scientist, inspired the audience at IMC19 and set the scene for a week of breakthroughs in his opening address. “An investment in this field (microscopy) is an investment in nanoparticles that target such things as a drug directly to malignant cells; 3D printed lattices that act like tiny factories for T-cells; vital in the new generation of cancer immunotherapies and more,” said Dr Finkel. “Without Microscopy, there is no modern science – end of story.” Professor Paul Munroe, Congress Co-Chair, said IMC19 had laid the foundations for great things. “We are excited to see where the collaborations from IMC19 take the industry, and what new technology and research will be showcased at the next congress in Korea in 2022,” he said. For more information on IMC19 visit: http://imc19.com. IMC19 brings the future of science into focus 2018-09-25T22:34:39Z imc19-brings-the-future-of-science-into-focus Critical discoveries and research that will help to transform health, science and industry are set to be the lasting legacy of the 19th International Microscopy Congress (IMC19), according to leaders of the scientific world. Held every four years, IMC19 saw more than 2,100 of the world’s top scientists and researchers from 48 countries come together at ICC Sydney to network, collaborate and discover the latest high-tech instrumentation and systems in microscopy and microanalysis. IMC19 also inspired the next generation of young scientists with its Schools Outreach Program, which welcomed 570 students from 19 schools. The program also featured a “Young Scientists Assembly” where 50 young scientists from around the world enjoyed the opportunity to discuss career planning with some of the most senior figures in the field. Professor Simon Ringer, Congress Chair, said the impact of IMC19 would be revealed over time from the global scientific community. “Innovations in microscopy enable us to extend our understanding of ourselves and the world around us. IMC19 brought together leaders in both the development and the application of microscopy in a huge range of disciplines” he said. “These connections will ultimately lead to breakthroughs, as researchers take the insights from advanced microscopy to develop a treatment for cancer, a vaccine for a virus, or a new 3D printed metallurgical alloy that improves our atmosphere by being strong and light and thereby fuel and greenhouse gas efficient.” The week-long scientific program included presentations by four expert plenary speakers, two Nobel Laureates, 150 invited presenters as well as 26 pre-congress workshops and 463 oral talks, bridging the primary streams of Frontier Issues; Instrumentation and Techniques; Physical and Life Sciences. The pioneering IMC19 Outreach Learning Program welcomed high school students to experience the very latest light and electron microscope equipment and a chance to meet with researchers and specialists in microscopy. Mrs Diane Fairweather, Head of Science, Riverstone Highschool, said the program allowed students to access cutting-edge technology. “This was a great STEM initiative by IMC19 and an amazing experience for the students who came. We don’t have these microscopes at our school and without the IMC19 Outreach Program, most of our students wouldn’t be able to use this equipment,” said Fairweather. “Our students are engaged; they are learning directly from experts on things like using the lens to focus – it’s a real hands-on experience.” The Outreach Program offered students access to the latest equipment including, VR, four scanning electron microscopes, 20 life microscopes and 3D printing. Equipment and demonstrations were supported by Zeiss, Leica, AXT, Keepad Interactive, NewSpec, ATA, Coherent, UNSW Art and Design and Me3D. Citing recent examples of some of the life-changing advancements that have developed as a direct result of microscopy, Dr Alan Finkel, Australia’s Chief Scientist, inspired the audience at IMC19 and set the scene for a week of breakthroughs in his opening address. “An investment in this field (microscopy) is an investment in nanoparticles that target such things as a drug directly to malignant cells; 3D printed lattices that act like tiny factories for T-cells; vital in the new generation of cancer immunotherapies and more,” said Dr Finkel. “Without Microscopy, there is no modern science – end of story.” Professor Paul Munroe, Congress Co-Chair, said IMC19 had laid the foundations for great things. “We are excited to see where the collaborations from IMC19 take the industry, and what new technology and research will be showcased at the next congress in Korea in 2022,” he said. For more information on IMC19 visit: http://imc19.com. Images: IMC19 Outreach Learning Program: Notes to editors: Interviews with Professor Simon Ringer, Congress Chair, IMC19 Interviews with Professor Paul Munroe, Congress Co-Chair, IMC 19 Media enquires contact Zadro Sinead Andrews | Account Coordinator | Zadro 02 9212 7867 | sinead@zadroagency.com.au Elizabeth Williams | Group Account Director | Zadro 02 9212 7867 | elizabeth@zadroagency.com.au NOTE: About the 19th International Microscopy Congress, 9 – 14 September 2018 Held once every four years, the International Microscopy Congress (IMC) is the preeminent meeting for researchers, practitioners, decision makers, national microscopy societies, industry partners and stakeholders involved in microscopy sciences from all over the world. Now in its 19th year, IMC19 ‘Microscopy: Bridging the Sciences’ is the only platform to bring together international, national and local professionals to discover new opportunities, uncover findings, learn techniques, collaborate with peers, and network with global leaders in the field of microscopy. About the Australian Microscopy & Microanalysis Society (AMMS) The Australian Microscopy & Microanalysis Society (AMMS) is Australia’s industry association for the promotion, co-operation and development of microscopy, microanalysis, and related techniques across a broad range of scientific disciplines. About the International Federation of Societies for Microscopy (IFSM) The International Federation of Societies for Microscopy (IFSM) comprises microscopy societies from all around the world to contribute to the advancement of microscopy in all its aspects. Microscope that gets to the heart of matter 2018-09-10T03:41:58Z microscope-that-gets-to-the-heart-of-matter Two Nobel Laureates and the NSW Chief Scientist & Engineer will officially unveil a vital piece of scientific infrastructure at the University of Sydney at a special event. The Thermo Fisher Themis-Z transmission electron microscope (TEM) has the highest resolution of any microscope in Australia. Its addition to the University of Sydney will provide researchers with unparalleled access to the mysteries of the atomic structure of materials. The 4.5-metre tall microscope is housed in the purpose-built $150 million Sydney Nanoscience Hub in a room that is shielded from electromagnetic interferences and ‘floats’ architecturally independent from the building to minimise vibrations. The resolution of this analysis technique is breathtaking. The machine can obtain images with resolution better than 0.06 billionths of a metre (0.06 nanometres). That is about 10 times smaller than the distance between silicon atoms or five times smaller than the distance between carbon atoms in diamond. The microscope, which is available for industry as well, also has applications in geosciences, mining, chemical and mechanical engineering. The new NSW Chief Scientist & Engineer, Professor Hugh Durrant-Whyte will unveil the device in his first week of his official functions alongside two Nobel Laureates in Chemistry, Prof. Dan Shechtman, The Technion, Israel and Professor Joachim Frank, Columbia University, USA, who are visiting Sydney for the 19th International Microscopy Congress (IMC19), which is jointly hosted by the University of Sydney and UNSW. Event details: What: Sydney Microscopy and Microanalysis launch event Aberration-corrected Transmission Electron Microscope Where: Research Foyer, Sydney Nanoscience Hub, Physics Road, University of Sydney When: Tuesday, 11 September 2018. 1.45pm for 2pm start. The 19th International Microscopy Congress (IMC19), 9-14 September, at ICC Sydney, will centre around the theme, Microscopy: Bridging the Sciences, promoting collaboration across the primary streams of Frontier Issues; Instrumentation and Techniques; Physical and Life Sciences. Complimentary media passes to the launch event are available; apply by sending your name, position and publication title to sinead@zadroagency.com.au. Complimentary media passes to IMC19 are also available; apply by sending your name, position and publication title to sinead@zadroagency.com.au. Image: The Thermo Fisher Themis-Z transmission electron microscope (TEM) How many scientists does it take to look through a microscope? 2018-09-06T02:03:09Z how-many-scientists-does-it-take-to-look-through-a-microscope More than 2,000 of the world’s top scientific brains will explore new findings, share research, and experience the latest state-of-the-art scientific microscopy equipment helping to reinvent and expand human knowledge, in Sydney next week. Field emission guns and new electron exploration systems are two of the many innovations and leading advancements in medical science that will be on show when the world’s largest microscopic community descends on Sydney for the 19th International Microscopy Congress (IMC19). The event, held every four years, starts on 9 September and will see presentations by world-renowned thought leaders and Nobel Laureates Professor Dan Shechtman and Professor Joachim Frank, from The Technion Israel, who won the 2017 Nobel Prize in chemistry for his work as founder of the single-particle cryo-electron microscopy (cryo-EM). By bringing together experts working across a multitude of academic and industrial fields, IMC19 will showcase - and define - how clear, crisp microscopic magnification, helps advance life on Earth. The genesis of our future’s most significant discoveries including reproductive breakthroughs and a step towards a cure for cancer can be found at this world-famous science event and the multi-million-dollar equipment on display. Tek-Event, Sydney based manufacturer of equipment dedicated to the field of human and animal reproductive technologies (ART), will showcase its range of brand new technologies providing a safe environment for tissue observation. Dieter Regel, Sales Director, Tek-Event, commented on the increasing requirement to provide accurate temperature control as well as CO2 and humidity in the latest technologies advancing human IVF laboratories, animal research and veterinary ART facilities. “Researchers who have the requirement to view cells or tissue microscopically, are often challenged when their environment is not stable. TEK-Event are excited to showcase our latest Cell-Tek microscope chambers, which helps create a controlled environment for examination in many fields of research, including the handling of oocytes and embryos in ART,” said Regel. Thermo Fisher Scientific will offer attendees a chance to take part in live demonstrations with technical experts working in innovative software and automated microscopy products and showcase a wide range of microscopy solutions. Attendees can register for a learning lunch with ZEISS, to experience their innovative microscopy technologies and applications. Sessions will cover 3D electron microscopy; X-ray microscopy and analytical microscopy and guests can win a ZEISS VR One Plus virtual reality headset. Tek-Event, Thermo Fisher Scientific and ZEISS will be joined by over 60 other confirmed exhibitors at IMC19, including Jeol, Quorum Technologies, Tescan, Technoorg Linda Co Ltd, Delmic, Hitachi, Leica and Nano Technologies Solutions. Delegates will also enjoy a range of activities and a vibrant social program in conjunction with the congress, aimed to engage attendees and help spark new connections among the scientific community. The IMC19 Outreach Learning Program will host 21 schools across Australia, to offer students the chance to undertake four storyline-based challenges, featuring the latest light and microscopy equipment alongside leading researchers and instrument specialists. Microscopy Australia will present a unique exhibition during the congress, Stories & Structures - New Connections, bringing together microscopy and Indigenous art through visual and story-telling parallels. The exhibition will showcase 21 artworks and 24 micrographs, as well as feature live painting by Indigenous artist Kurun Warun in residence. The 19th International Microscopy Congress (IMC19), 9-14 September, at ICC Sydney, will centre around the theme, Microscopy: Bridging the Sciences, promoting collaboration across the primary streams of Frontier Issues; Instrumentation and Techniques; Physical and Life Sciences. Exposing “serial killers”, Quasi-Periodic Materials, and Sub-particles at IMC19 Sydney 2018-08-06T04:14:11Z exposing-serial-killers-quasi-periodic-materials-and-sub-particles-at-imc19-sydney Examining ‘serial killer’ cells and their behaviour will be at the centre of leading Australian Immunologist, Dr Misty Jenkins’, plenary talk - Understanding Serial Killers: Investigating the Function of Cytotoxic T Lymphocytes using Microscopy’ at IMC19 in Sydney next month. Approximately 1,600 Australians are diagnosed with brain cancer each year. Dr Misty Jenkins, NHMRC RD Wright Fellow and Laboratory Head at Walter Eliza Hall Institute for Medical Research, is seeking to change that, and will share how microscopy is directing her research into fighting brain cancer. Ahead of the IMC19 Congress, Dr Jenkins shares how her research is using imaging to understand how killer T-cells in the immune system could be modified to develop a cure for brain cancer. “T-cells are like the snipers of the immune system, they take out very specific targets and throw grenades at them to make them blow up. These cells are genetically designed to kill cancer cells, and we image this process to uncover new insights into the behaviour of these engineered killers,” said Dr Jenkins. With a series of accolades including the L’Oréal for Women in Science Fellowship (2013) and the Westpac/Australian Financial Review Top100 Women of Influence Award (2016), Ballarat-born Dr Jenkins is a testament to the high calibre of scientists that will be representing Australia at the Congress. It is such an exciting time for science, and this is our chance to show the world the great work we are doing on our own shores. But it is also a rare and unique opportunity to collaborate with, learn from and share the stage with renowned scientists from across the globe,” said Dr Jenkins. Dr Jenkins will be joined by the world’s most prominent plenary speakers including: Nobel Laureate Professor Dan Shechtman, from Technion - Israel Institute of Technology, presenting on The Discovery of Quasi-Periodic Materials – The Role of TEM Associate Professor Jennifer Dionne, from Materials Science and Engineering at Stanford, USA, who recently featured on Oprah Winfrey’s list of “50 things that will make you say ‘Wow’!” with In Situ Visualisation of Photochemical Transformations at the Single and Sub-particle Level Professor Zhiwei Shan, from Xi’an Jiaotong University, China, who has published over 70 prestigious papers and presented more than 130 invited talks discussing Mechanical Testing Laboratory Inside TEM The 19th International Microscopy Congress (IMC19), 9-14 September, at ICC Sydney, will centre around the theme, Microscopy: Bridging the Sciences, promoting collaboration across the primary streams of Frontier Issues; Instrumentation and Techniques; Physical and Life Sciences. To register and for more information: http://imc19.com Image: Dr. Misty Jenkins, Walter Eliza Hall Institute for Medical Research, Australia Professor Dan Shechtman, The Technion, Israel Assoc. Prof. Jennifer Dionne, Stanford, USA Prof. Zhiwei Shan, Xi’an Jiaotong University, China How cannabis research revealed the Endocannabinoid System and its influence on homeostasis 2018-07-23T00:29:02Z how-cannabis-research-revealed-the-endocannabinoid-system-and-its-influence-on-homeostasis Medicinal cannabis, its use and benefits for illness and disease are still being appreciated, and with new legislation introduced in Australia to legalise the use and supply of medicinal cannabis means the spotlight is on the medical profession to see how this herbal medicine can treat chronic illness. Justin Sinclair, an Australian Pharmacognosist and Educator will share his insights at the upcoming A5M Medical Conference in Melbourne and present: Cannabis Phytochemistry and the Endocannabinoid System. For more than 15 years Justin’s research and experience spans several scientific disciplines, including cultivation, botany, plant genetics, ethnopharmacology, and analytical phytochemistry. As coordinator for the Australian Medicinal Cannabis Research and Education Collaboration at NICM Health Research Institute, Western Sydney University, Sinclair is an advocate for medicinal cannabis research and believes worldwide studies have proven medicinal cannabis has provided patients with significant health benefits. “In countries where cannabis is legal, where they have a standardised medical supply of cannabis, the majority of patients are utilising it to treat chronic pain. Studies have shown benefits for many other illnesses, such as intractable epilepsy (non-responsive to normal modern pharmacological treatment), and evidence from overseas countries has demonstrated that medicinal cannabis may reduce spasticity in multiple sclerosis, amongst other illnesses. “Years of research has discovered a broad ranging neuro-modulatory system involved in most facets of homeostasis. This system is known as the Endocannabinoid System and was revealed only through research conducted on the Cannabis genus,” acknowledged Mr Sinclair. Sinclair believes that this is one of the greatest scientific discoveries in the last 50 years, with ongoing research into the endocannabinoid system likely to elucidate our understanding of various human diseases, with existing research suggesting that the endocannabinoid system is one of the primary regulators of homeostasis in the body. Speaking at the A5M Medical Conference in Melbourne, Mr Sinclair will discuss the discovery of the Endocannabinoid System (ECS) with a focus on receptors, ligands and enzymes that are involved in this modulator of homeostasis within the body. The 12th Annual A5M Anti-Ageing & Aesthetic Conference will take place on Saturday 4 and Sunday 5 August 2018 delivering cutting-edge research into this new frontier at Sofitel Melbourne on Collins, with a Preconference Workshop on Friday, 3 August 2018. To register for the Conference, visit: www.a5m.net Western Sydney University’s NICM Health Research Institute (NICM) is Australia’s leader in integrative and complementary medicine research and policy. As an ERA 5 ranking institute, NICM is globally recognised for its world-class research and innovations in integrative and complementary medicine. An initiative of NICM, the Australian Medicinal Cannabis Research and Education Collaboration (AMCREC) brings together a highly skilled transdisciplinary team and state-of-the-art facilities, providing a platform for high-quality, independent research, education and consultancy services in medicinal cannabis. For more information about NICM Health Research Institute, visit: www.nicm.edu.au Hashtag: #A5MConf18 - ENDS - - ENDS - Media Contacts: For further information, images, interviews or industry commentary, please contact: Debbie Bradley, Group Account Director | +61 2 9212 7867 | debbie@zadroagency.com.au Julie Donovan, Senior Account Manager | +61 2 9212 7867 | julie@zadroagency.com.au Notes to editor: The AustralAsian Academy of Anti-Ageing Medicine (A5M) is committed to providing medical practitioners, pharmacists and allied health professionals with support and education about the latest evidence-based methods to improve patient outcomes as they age - both internal and external. A5M is currently about to celebrate its 12th Annual Conference, one of the longest running conferences of its kind, which will take place on Saturday 4th and Sunday 5th August at Sofitel Melbourne on Collins For more information on A5M visit: www.A5M.net Connect through social media channels: Facebook: /A5Meducation Twitter: /A5Meducation LinkedIn: /A5M ATMS LAUNCH ‘HOW DARE THEY!’ CAMPAIGN 2018-07-10T23:10:00Z atms-launch-how-dare-they-campaign The Australian Traditional-Medicine Society (ATMS) has launched the How Dare They! campaign aimed at the Federal Parliament, as the Coalition Government moves to scrap the private health insurance rebate on natural therapies. The move will make it more expensive for Australians with private health insurance to visit their local natural health practitioners. Charles Wurf, Chief Executive Officer, ATMS, said Australians with private health insurance already pay a premium so that they can choose the best medical treatment for themselves and for their families. “Natural therapies are vital to not only the economy but to everyday Australians, with 68.9% of Australians having used at least one form of natural therapy in the last 12 months[1] and 69.2 million visits to natural medicine practitioners[2]. “For many Australians private healthcare is about choice. Removing the private health insurance rebate on natural therapies seriously limits the choices available to Australians to manage their personal health and may affect the preventative steps they take to keep their families well/healthy,” said Mr Wurf. With the natural medicines industry employing over 36,000 Australians[3], the potential economic effects are also of concern. “With 28,000 Australian small businesses operating in the natural medicine industry, it’s not only consumers of natural medicine who will be impacted by this move,” concluded Mr Wurf. ATMS ask that Minister Hunt reconsider this policy and reinstate choice back into the Australian private health insurance system. The online campaign will run parallel to planned Federal Government consultation on this issue in July 2018, with the new private health insurance rules being finalised for commencement in April 2019. More information on the collaborative How Dare They! campaign can be found here: www.howdarethey.com.au For more on ATMS visit: www.atms.com.au -ENDS- NOTES TO EDITORS: Interviews with: Charles Wurf, CEO, ATMS, are available on request through the below contacts For media enquiries please contact: Jessica McLean, Account Manager, Zadro P: 02 9212 7867 | jessica@zadroagency.com.au Debbie Bradley, Group Account Director, Zadro P: 02 9212 7867 | felicity@zadroagency.com.au Image: Charles Wurf, CEO, ATMS About the Australian Traditional-Medicine Society: The Australian Traditional-Medicine Society (ATMS) is the leader of the natural medicine industry, promoting and representing professional practitioners of natural medicine, who are encouraged to pursue the highest ideals of professionalism in their natural medicine practice and education. As Australia’s largest national professional association for natural medicine practitioners, ATMS is a multi-disciplinary association representing over 10,000 accredited practitioners throughout Australia. ATMS was founded in 1984 and is an incorporated not-for-profit company. In 2014 ATMS celebrated their 30th anniversary representing natural medicine practitioners in Australia. ATMS is governed by a Board of Directors, with specialised departments for Massage Therapy, Traditional Chinese Medicine, Homeopathy, Nutrition, Naturopathy and Western Herbal Medicine. [1] https://www.ncbi.nlm.nih.gov/pubmed/17718647 Xue et al. 2007 Complementary and Alternative Medicine Use in Australia: A National Population-Based Survey [2] Australian Department of Health and Ageing. Medicare Statistical data for the June Quarter 2005. Available from: http://www.health.gov.au/, 2005 [3] IBIS World Report, March 2018 Medical Conference to Address Inner and Outer Health 2018-07-09T04:13:59Z medical-conference-to-address-inner-and-outer-health In August 2018, the AustralAsian Academy of Anti-Ageing Medicine (A5M) will host their 12th Annual Conference and Expo in Melbourne, presenting an unrivalled line up of Australian and international aesthetic, integrative and anti-ageing experts to build the bridge between inner and outer health. With the continued integration of evidence-based conventional medicine with the complementary and aesthetics industry and a rise in a multidisciplinary and holistic approach to patient care – the A5M Conference will provide a truly encompassing view for medical professionals to learn, discuss and drive the future of integrative medicine across Australasia. Delegates will hear from over 20 speakers discussing interventions for both internal and external causes of chronic conditions, while focusing on examining the impact that exercise and lifestyle, diet and nutrition, supplementation, hormonal/metabolic imbalance and genetic factors, have on the ageing process. EVENT DETAILS: WHAT: AustralAsian Academy of Anti-Ageing Medicine Annual Conference WHEN: Saturday 4th and Sunday 5th August 2018 TIME: 8:00am – 5:30pm WHERE: Sofitel Melbourne on Collins PRICE: Members: $1050; Non-members: $1250 WEBSITE: https://www.a5m.net/conference-information/2018-annual-conference The Conference covers a range of topics including: Connecting Inner and Outer Health Mitochondrial Dysfunction and Chronic Disease Telomeres, Cancer and Ageing Metabolic and Hormonal Health Issues Reversing Mild Cognitive Decline Brain Health Healthy ageing and wellbeing New Frontiers in Medicine: Medical Cannabis And much more! To register, visit: https://www.a5m.net/conference-information/a5m-annual-conference/2018-a5m-conference Hashtag: #A5MConf18 - ENDS - For further information, images, interviews or industry commentary, please contact: Debbie Bradley, Account Director | +612 9212 7867 | debbie@zadroagency.com.au Julie Donovan, Senior Account Manager | +612 9212 7867 | julie@zadroagency.com.au Notes to editor: The AustralAsian Academy of Anti-Ageing Medicine (A5M) is committed to providing medical practitioners, pharmacists and allied health professionals with support and education about the latest evidence-based methods to improve patient outcomes as they age - both internal and external. A5M is currently about to celebrate its 12th Annual Conference, one of the longest running conferences of its kind, which will take place on Saturday 4th and Sunday 5th August at Sofitel Melbourne on Collins For more information on A5M visit: www.A5M.net Connect through social media channels: Facebook: /A5Meducation Twitter: /A5Meducation LinkedIn: /A5M The role of A5M is to develop and promote all aspects of preventative, anti-ageing and integrative medicine among practitioners and the community A5M is dedicated to educating medical practitioners, allied healthcare professionals, scientist and researchers by providing training, certification and continuing education in preventative, integrative and anti-ageing medicine As the leading academic body of Anti-Ageing Medicine in AustralAsia, A5M offers Certification and access to a world-class Fellowship Program in Anti-Ageing, Regenerative and Functional Medicine with Metabolic Medicine Institute (MMI) and the American Academy of Anti-Ageing Medicine (A4M) The principles of A5M education and programs are based on scientific evidence based medicine, which involves the integration of the five pillars of ageing: diet and nutrition, supplementation, hormones, genetics and exercise and lifestyle Bridging the Sciences at the 19th International Microscopy Congress 2018-06-03T23:56:20Z bridging-the-sciences-at-the-19th-international-microscopy-congress Sydney will host Nobel Laureates Professor Dan Shechtman, from Technion - Israel Institute of Technology and Professor Joachim Frank, from Columbia University, USA together with global authorities at the world’s largest and most diverse gathering of microscopy and microanalysis professionals at the 19th International Microscopy Congress (IMC19), 9 – 14 September 2018, in Sydney. Hosted by the internationally renowned Australian Microscopy & Microanalysis Society (AMMS) and the International Federation of Societies for Microscopy (IFSM), IMC19 will shine a light on Australia’s significant and exciting contribution to a collaborative, multidisciplinary industry that affects everyone’s lives - every single day. IMC19 will also welcome local and international visionaries, including Dr Misty Jenkins, Walter Eliza Hall Institute for Medical Research, Australia, Associate Professor Jennifer Dionne, Stanford University, USA, and Professor Zhiwei Shan, Xi’an Jiaotong University, China. They, together with the world’s scientific leaders will debate and discuss the latest insights and approaches in policy, research and programs relevant to practitioners, providers, government and academia. Professor Simon Ringer, Congress Chair, IMC19 said it was an honour to be highlighting the work Australians are doing in microscopy to the world through this highly coveted event. “IMC19 has an impressive line-up of global thought leaders set to challenge and explore the latest technology and practices in microscopy. “However, this is Australia’s scientific community’s chance to shine and we believe our international peers will be pleasantly surprised by the amount and depth of advancements happening on our shores. “The exhibition floor will be awash with cutting-edge technology, imaging techniques and state-of-the-art products and services from around Australia and the globe, that are destined to transform our understanding of the world around us. “The Congress is the only one of its kind, crucial for bringing together the brightest scientific and technical minds to collaborate, cross-pollinate and bridge disciplines,” said Ringer. IMC19 is offering 50 young scientists an opportunity to attend an unmissable platform to network with experts in their field, the IFSM Young Scientists Assembly. Held on 9 September 2018 at the University of Sydney, they will meet, discuss and learn from academic and industry leaders. The 19th International Microscopy Congress (IMC19) will centre around the theme, Microscopy: Bridging the Sciences, promoting collaboration across the primary streams of Frontier Issues; Instrumentation and Techniques; Physical and Life Sciences. To register and for more information: http://imc19.com Australian Scientists Under the Microscope 2018-05-22T22:30:00Z australian-scientists-under-the-microscope Sydney will host Nobel Laureates Professor Dan Shechtman, from Technion - Israel Institute of Technology and Professor Joachim Frank, from Columbia University, USA together with global authorities at the world’s largest and most diverse gathering of microscopy and microanalysis professionals at the 19th International Microscopy Congress (IMC19), 9 – 14 September 2018, in Sydney. Hosted by the internationally renowned Australian Microscopy & Microanalysis Society (AMMS) and the International Federation of Societies for Microscopy (IFSM), IMC19 will shine a light on Australia’s significant and exciting contribution to a collaborative, multidisciplinary industry that affects everyone’s lives - every single day. IMC19 will also welcome local and international visionaries, including Dr Misty Jenkins, Walter Eliza Hall Institute for Medical Research, Australia, Associate Professor Jennifer Dionne, Stanford University, USA, and Professor Zhiwei Shan, Xi’an Jiaotong University, China. They, together with the world’s scientific leaders will debate and discuss the latest insights and approaches in policy, research and programs relevant to practitioners, providers, government and academia. Professor Simon Ringer, Congress Chair, IMC19 said it was an honour to be highlighting the work Australians are doing in microscopy to the world through this highly coveted event. “IMC19 has an impressive line-up of global thought leaders set to challenge and explore the latest technology and practices in microscopy. “However, this is Australia’s scientific community’s chance to shine and we believe our international peers will be pleasantly surprised by the amount and depth of advancements happening on our shores. “The exhibition floor will be awash with cutting-edge technology, imaging techniques and state-of-the-art products and services from around Australia and the globe, that are destined to transform our understanding of the world around us. “The Congress is the only one of its kind, crucial for bringing together the brightest scientific and technical minds to collaborate, cross-pollinate and bridge disciplines,” said Ringer. IMC19 is offering 50 young scientists an opportunity to attend an unmissable platform to network with experts in their field, the IFSM Young Scientists Assembly. Held on 9 September 2018 at the University of Sydney, they will meet, discuss and learn from academic and industry leaders. The 19th International Microscopy Congress (IMC19) will centre around the theme, Microscopy: Bridging the Sciences, promoting collaboration across the primary streams of Frontier Issues; Instrumentation and Techniques; Physical and Life Sciences. To register and for more information: http://imc19.com ‘Eat for Your Eyes’ this Macula Month (1-31 May) 2018-05-22T22:14:55Z eat-for-your-eyes-this-macula-month-1-31-may-4 ‘Eat for Your Eyes’ this Macula Month (1-31 May) Macular disease is the leading cause of blindness in Australia Knowledge is definitely power in the defence against macular disease, yet a recent study by Macular Disease Foundation Australia has highlighted the need for Australians to be more aware of macular disease and how to minimise the risk. Macular disease is a term used to describe a number of diseases that affect the macula (located at the centre of the retina, at the back of the eye). The macula is responsible for our detailed central vision – what we see straight in front of us. Two of the most common diseases affecting the macula include diabetic eye disease (such as diabetic retinopathy) and age-related macular degeneration. Despite macular disease being the leading cause of blindness in Australia, a YouGov Galaxy study, commissioned by Macular Disease Foundation Australia, indicates that 91 per cent of Australians are unsure or unaware of the function of the macula. One of the most common diseases affecting the macula, diabetic eye disease is the leading cause of preventable blindness in working-aged Australians. Yet, the study shows that 60 per cent of people diagnosed with diabetes do not know what the macula’s function is. Alarmingly, 64 per cent of those diagnosed with diabetes are unaware that the eyes can be affected by diabetes. When it comes to reducing the risk of macular disease, the study showed that almost a quarter (23 per cent) of Australians aged 50 and over don’t know what to do to reduce the risk of macular disease. So, what can you do to reduce the risk of macular disease? According to Macular Disease Foundation Australia, there are some steps that can reduce the risk of macular disease. These include regularly having a comprehensive eye test, including a macula check, don’t smoke and maintain an eye-healthy lifestyle and diet. What is an eye-healthy diet? Macular Disease Foundation Australia offers these three tips: Eat a healthy, well-balanced diet. A well-balanced diet high in antioxidants, vitamins and other nutrients can help keep our eyes healthy. Eat fish two to three times a week.Dark green leafy vegetables and fresh fruit daily, and a handful of nuts per week. Whenever possible, choose low glycemic index (GI) carbohydrates instead of high GI. Ita Buttrose, AO OBE, Patron of Macular Disease Foundation Australia says, “May is Macula Month, and what better time to make the appointment for a comprehensive eye test. Whether you are diabetic, aged over 50 or, like me, are at higher risk of macular disease because of family history, I encourage everyone to take steps now to reduce their risk of macular disease. My family history means that I have a 50 per cent chance of developing macular degeneration, and my children are equally at risk. Consequently, we all do some kind of regular exercise, watch our weight, eat well and have regular eye tests. As a journalist and author, I can’t imagine losing my sight and never being able to read again.” Ms Dee Hopkins, Chief Executive Officer of Macular Disease Foundation Australia says, “Nutrition plays an important role in optimising macular health and reducing the risk of macular disease. Eating a healthy, well-balanced diet which includes eye healthy foods is good for overall wellbeing, as well as eye health.” “Important antioxidants for eye health include lutein and zeaxanthin. These are present in high concentrations in a healthy macula and help to protect the eye. They are found in dark green leafy vegetables like spinach and kale, as well as naturally yellow fruit and vegetables like sweet corn and capsicum. In addition, vitamin C, vitamin E, zinc and selenium are important antioxidants for a healthy macula. “Many people in our community are at risk of developing macular disease but just don’t know it. Those over 50 are at higher risk of age-related macular degeneration, and everyone with diabetes is at risk of developing vision loss from diabetic eye disease. “No matter what your age, if you have sudden changes in your vision you need to have your eyes tested immediately. “During Macula Month, we hope that people think about their macula health, learn the risk factors associated with macular disease and have a regular, comprehensive eye examination, including having their macula checked.” For information about macular disease, or to talk about what to do if you or a loved one has been diagnosed, contact Macular Disease Foundation Australia on Ph. 1800 111 709 or visit www.mdfoundation.com.au Download your free Macula Menu here ENDS For media enquiries, please contact: Cheryl Pettinau, QUAY Communications Kylie Ironside, QUAY Communications Ph. 02 9386 9161 or 0424 157 714 Ph. 02 9386 9161 or 0439 918 078 E. cheryl@quaycommunications.com.au E. kylie@quaycommunications.com.au Notes to the Editor: About Macular Disease Foundation Australia Macular Disease Foundation Australia’s (MDFA) vision is to reduce the incidence and impact of macular disease in Australia through education, awareness, research, support services and representation. It is a national charity providing independent, free, expert advice on preventing and living well with macular disease. For more information call 1800 111 709 or visit www.mdfoundation.com.au About Macula Month – 1 to 31 May 2018 Macula Month is an initiative of Macular Disease Foundation Australia and runs for the month of May. It is an annual campaign designed to raise awareness of macular disease, which includes age-related macular degeneration and diabetic eye disease, along with other less common diseases of the macula. Macular disease is the leading cause of vision loss and blindness in Australia. ‘Awareness of macular disease’, study conducted by YouGov Galaxy, commissioned by Macular Disease Foundation Australia between 1 and 4 March, 2018, comprising 1,020 Australians aged 18 years and older. Macular Disease Foundation Australia – Macular Degeneration booklet ‘Eyes on the future - A clear outlook on age-related macular degeneration’. Report by Deloitte Access Economics & Macular Degeneration Foundation, 2011. 2018 prevalence estimates are derived from a straight-line extrapolation between 2015 and 2020 estimates in this report. Guidelines for the Management of Diabetic Retinopathy. NHMRC 2008.